Bayer Collaborate with Women’s Hospital and Massachusetts General Hospital to Launch Joint Lab Targeting Chronic Lung Diseases

 Bayer Collaborate with Women’s Hospital and Massachusetts General Hospital to Launch Joint Lab Targeting Chronic Lung Diseases

Bayer Collaborates with Women’s Hospital and Massachusetts General Hospital to Launch Joint Lab Targeting Chronic Lung Diseases

Shots:

  • Bayer to fund $30M to the joint research projects for the next 5yrs. The joint lab will host the scientist from all the partners to research on new therapies for chronic lung cancer 
  • The launch of a lab will robust Bayer’s existing presence in Boston and will combine Bayer’s drug discovery & development expertise with BHW & MGH’s clinical expertise, understanding of disease mechanisms, data analysis capabilities
  • The new lab at BWH is in the Longwood Medical and Academic Area, consisting of 20 experts from all three organization and will share equal rights of the research findings at the new lab. In 2018, Bayer established its first joint lab in collaboration with the Broad Institute of MIT and Harvard focusing CV diseases in Boston

Click here to­ read full press release/ article | Ref: Bayer | Image: Fortune

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post